NFE2L2 and dry eye syndrome: Yang et al. proposed that NRF2 activation in KCs by inflammatory cytokines (e.g., IL-17 and IL-22) promotes KC proliferation through the upregulation of K6/K16/K17 and releases inflammatory cytokines and chemokines [97].